SpyGlass Pharma was Co-founded by Dr. Malik Y. Kahook, MD and Glenn Sussman. The company is focused on the development of novel treatments for chronic ophthalmic diseases based on technology originally developed in the Sue Anschutz-Rodgers Eye Center of the University of Colorado School of Medicine.
Location: United States, California, Aliso Viejo
Member count: 11-50
Total raised: $90M
Founded date: 2019
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 10.07.2023 | Series C | $90M | New Enterp... | finsmes.co... |
Mentions in press and media 7
| Date | Title | Description | Source |
| 10.07.2023 | SpyGlass Pharma Closes $90M Series C Financing | SpyGlass Pharma, an Aliso Viejo, CA-based ophthalmic therapeutics company, raised $90M in Series C f... | finsmes.co... |
| 10.07.2023 | SpyGlass Pharma Scores $90M Series C | ALISO VIEJO, CA, SpyGlass Pharma, a company developing a treatment for glaucoma and other chronic ... | vcnewsdail... |
| 10.07.2023 | SpyGlass Pharma Completes $90 Million Series C Financing to ... | www.spyglasspharma.com ALISO VIEJO, Calif. (PRWEB) July 10, 2023 SpyGlass Pharma, a privately-held... | prweb.com/... |
| 15.09.2022 | SpyGlass Pharma to Unveil Innovative Drug Delivery Platform ... | SpyGlass Pharma, Inc. ALISO VIEJO, Calif. (PRWEB) September 15, 2022 SpyGlass Pharma, a privately-... | prweb.com/... |
| 20.07.2021 | SpyGlass Pharma Appoints Industry Veteran Patrick Mooney as ... | ALISO VIEJO, Calif. (PRWEB) July 20, 2021 SpyGlass Pharma (“SpyGlass”), a privately-held ophthalmic... | prweb.com/... |
| - | SpyGlass Pharma: Ophthalmic Therapeutics Company Closes $90 ... | SpyGlass Pharma – a privately-held ophthalmic therapeutics company- recently announced the closing o... | pulse2.com... |
| - | Spyglass Pharma | “For all cataract surgeons managing glaucoma patients: SpyGlass Pharma is introducing the world’s fi... | fastfounde... |